Nelson G - Search Results

1

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.

Nelson G, Fotopoulou C, Taylor J, Glaser G, Bakkum-Gamez J, Meyer LA, Stone R, Mena G, Elias KM, Altman AD, Bisch SP, Ramirez PT, Dowdy SC. Nelson G, et al. Gynecol Oncol. 2023 Jun;173:58-67. doi: 10.1016/j.ygyno.2023.04.009. Epub 2023 Apr 21. Gynecol Oncol. 2023. PMID: 37086524 Free article. Review.

2

Vacuum assisted wound closures in gynaecologic surgery.

Altman AD, Nelson G, Nation J, Chu P, Ghatage P. Altman AD, et al. Among authors: nelson g. J Obstet Gynaecol Can. 2011 Oct;33(10):1031-1037. doi: 10.1016/S1701-2163(16)35052-6. J Obstet Gynaecol Can. 2011. PMID: 22014780 Review.

3

Optimal debulking targets in women with advanced stage ovarian cancer: a retrospective study of immediate versus interval debulking surgery.

Altman AD, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: nelson g. J Obstet Gynaecol Can. 2012 Jun;34(6):558-566. doi: 10.1016/S1701-2163(16)35272-0. J Obstet Gynaecol Can. 2012. PMID: 22673172

4

Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.

Altman AD, Nelson GS, Chu P, Nation J, Ghatage P. Altman AD, et al. Int J Gynecol Cancer. 2012 Jul;22(6):1006-12. doi: 10.1097/IGC.0b013e31825b7de8. Int J Gynecol Cancer. 2012. PMID: 22740004 Review.

5

Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study.

Altman AD, Thompson J, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: nelson g. J Obstet Gynaecol Can. 2012 Jul;34(7):664-72. doi: 10.1016/s1701-2163(16)35320-8. J Obstet Gynaecol Can. 2012. PMID: 22742486

6

Architectural patterns of ovarian/pelvic high-grade serous carcinoma.

Bromley AB, Altman AD, Chu P, Nation JG, Nelson GS, Ghatage P, Kalloger SE, Han G, Köbel M. Bromley AB, et al. Among authors: nelson gs. Int J Gynecol Pathol. 2012 Sep;31(5):397-404. doi: 10.1097/PGP.0b013e31824c2372. Int J Gynecol Pathol. 2012. PMID: 22833078

7

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.

Altman AD, Nelson GS, Ghatage P, McIntyre JB, Capper D, Chu P, Nation JG, Karnezis AN, Han G, Kalloger SE, Köbel M. Altman AD, et al. Among authors: nelson gs. Mod Pathol. 2013 Sep;26(9):1255-63. doi: 10.1038/modpathol.2013.55. Epub 2013 Apr 5. Mod Pathol. 2013. PMID: 23558569 Free article.

8

The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.

Altman AD, Liu XQ, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: nelson g. Int J Gynecol Cancer. 2013 Nov;23(9):1569-76. doi: 10.1097/IGC.0b013e3182a57ff6. Int J Gynecol Cancer. 2013. PMID: 24100588

9

PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.

McIntyre JB, Nelson GS, Ghatage P, Morris D, Duggan MA, Lee CH, Doll CM, Köbel M. McIntyre JB, et al. Gynecol Oncol. 2014 Jan;132(1):188-93. doi: 10.1016/j.ygyno.2013.11.015. Epub 2013 Nov 19. Gynecol Oncol. 2014. PMID: 24262879

10

Enhanced recovery pathways in gynecologic oncology.

Nelson G, Kalogera E, Dowdy SC. Nelson G, et al. Gynecol Oncol. 2014 Dec;135(3):586-94. doi: 10.1016/j.ygyno.2014.10.006. Epub 2014 Oct 12. Gynecol Oncol. 2014. PMID: 25316179 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,859 results

Search Page